M.E. Allison & Co., Inc. Merck & Co., Inc. Transaction History
M.E. Allison & Co., Inc.
- $101 Billion
- Q1 2025
A detailed history of M.E. Allison & Co., Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, M.E. Allison & Co., Inc. holds 6,449 shares of MRK stock, worth $549,454. This represents 0.57% of its overall portfolio holdings.
Number of Shares
6,449
Previous 5,448
18.37%
Holding current value
$549,454
Previous $542 Million
6.8%
% of portfolio
0.57%
Previous 0.6%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,905Shares Held
1.85BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$21.4 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.3 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.21 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.76 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $216B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...